Other Diseases of Blood and Blood-Forming Organs Recruiting Phase 1 / 2 Trials for Venetoclax (DB11581)

Also known as: Disorder hematologic / Disorder blood (NOS) / Blood disorder NOS / Blood disorder / Blood/blood forming organ NOS / Dyscrasia blood (NOS) / Haematological disorders / Hematologic disorder / Hematologic Diseases / Diseases of blood and blood-forming organs, unspecified / Blood dyscrasia / Blood dyscrasia NOS / Disease of blood and blood-forming organs, unspecified / Unspecified diseases of blood and blood-forming organs / Diseases of blood and blood-forming organs, other

IndicationStatusPhase
DBCOND0082202 (Other Diseases of Blood and Blood-Forming Organs)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03471260Ivosidenib and Venetoclax With or Without Azacitidine in Treating Participants With IDH1 Mutated Hematologic MalignanciesTreatment
NCT03214562Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid LeukemiaTreatment